Eisler Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$68.2M Buy
90,300
+20,700
+30% +$15.4M 0.3% 52
2025
Q2
$54.3M Buy
69,600
+25,200
+57% +$19.6M 0.33% 51
2025
Q1
$36.7M Sell
44,400
-6,300
-12% -$5.24M 0.26% 73
2024
Q4
$39.5M Buy
+50,700
New +$42M 0.19% 107

Other funds holding LLY

Eisler Capital Management's LLY Position: Q3 2025 in Review

Eisler Capital Management increased its Eli Lilly (LLY) stake by 40% in Q3 2025, buying an estimated $2.68M and bringing the position to 12,676 shares worth $9.57M. The position accounts for 0.04% of the portfolio, ranked #226.

Eisler Capital Management first reported a position in LLY in Q4 2024 and has held it in 4 quarters since. The position peaked at $13.7M in Q4 2024. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Eisler Capital Management held 12,676 shares of Eli Lilly worth $9.57M as of Q3 2025.
  • Eisler Capital Management bought 3,596 Eli Lilly shares in Q3 2025, an estimated $2.68M.
  • Eli Lilly made up 0.04% of Eisler Capital Management's portfolio in Q3 2025, its #226 holding.
  • Eisler Capital Management first reported a position in Eli Lilly in Q4 2024 and has held it in 4 quarters since.
  • Eisler Capital Management's Eli Lilly position peaked at $13.7M in Q4 2024.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Eisler Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.